Unknown

Dataset Information

0

Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with Rifaximin in Cirrhosis: implications for the gut-liver-brain axis.


ABSTRACT:

Unlabelled

Minimal hepatic encephalopathy (MHE) impairs daily functioning in cirrhosis, but its functional brain impact is not completely understood. To evaluate the effect of rifaximin, a gut-specific antibiotic, on the gut-liver-brain axis in MHE.

Hypothesis

Rifaximin will reduce endotoxemia, enhance cognition, increase activation during working memory(N-back) and reduce activation needed for inhibitory control tasks.

Methods

Cirrhotics with MHE underwent baseline endotoxin and cognitive testing, then underwent fMRI, diffusion tensor imaging and MR spectroscopy(MRS). On fMRI, two tasks; N-back (outcome: correct responses) and inhibitory control tests(outcomes: lure inhibition) were performed. All procedures were repeated after 8 weeks of rifaximin. RESULTS were compared before/after rifaximin.

Results

20 MHE patients (59.7 years) were included; sixteen completed pre/post-rifaximin scanning with 92% medication compliance. Pre-rifaximin patients had cognitive impairment. At trial-end, there was a significantly higher correct 2-back responses, ICT lure inhibitions and reduced endotoxemia(p = 0.002). This was accompanied by significantly higher activation from baseline in subcortical structures (thalamus, caudate, insula and hippocampus) and left parietal operculum (LPO) during N-back, decrease in fronto-parietal activation required for inhibiting lures, including LPO during ICT compared to baseline values. Connectivity studies in N-back showed significant shifts in linkages after therapy in fronto-parietal regions with a reduction in fractional anisotropy (FA) but not mean diffusivity (MD), and no change in MRS metabolites at the end of the trial. A significant improvement in cognition including working memory and inhibitory control, and fractional anisotropy without effect on MD or MRS, through modulation of fronto-parietal and subcortical activation and connectivity was seen after open-label rifaximin therapy in MHE.

SUBMITTER: Ahluwalia V 

PROVIDER: S-EPMC4155029 | biostudies-literature | 2014 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with Rifaximin in Cirrhosis: implications for the gut-liver-brain axis.

Ahluwalia Vishwadeep V   Wade James B JB   Heuman Douglas M DM   Hammeke Thomas A TA   Sanyal Arun J AJ   Sterling Richard K RK   Stravitz R Todd RT   Luketic Velimir V   Siddiqui Mohammad S MS   Puri Puneet P   Fuchs Michael M   Lennon Micheal J MJ   Kraft Kenneth A KA   Gilles HoChong H   White Melanie B MB   Noble Nicole A NA   Bajaj Jasmohan S JS  

Metabolic brain disease 20140304 4


<h4>Unlabelled</h4>Minimal hepatic encephalopathy (MHE) impairs daily functioning in cirrhosis, but its functional brain impact is not completely understood. To evaluate the effect of rifaximin, a gut-specific antibiotic, on the gut-liver-brain axis in MHE.<h4>Hypothesis</h4>Rifaximin will reduce endotoxemia, enhance cognition, increase activation during working memory(N-back) and reduce activation needed for inhibitory control tasks.<h4>Methods</h4>Cirrhotics with MHE underwent baseline endotox  ...[more]

Similar Datasets

| S-EPMC8518409 | biostudies-literature
| S-EPMC5621837 | biostudies-literature
| S-EPMC6166307 | biostudies-literature
| S-EPMC10427858 | biostudies-literature
| S-EPMC5145145 | biostudies-literature
| S-EPMC10008641 | biostudies-literature
| S-EPMC4880966 | biostudies-literature
| S-EPMC10787503 | biostudies-literature
| S-EPMC4476954 | biostudies-literature
| S-EPMC6870317 | biostudies-literature